Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. Read more about Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer. Read more about 24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC. Read more about Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711). Read more about Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711).
CD74-ROS1 Fusion in NSCLC Detected by Hybrid Capture-Based Tissue Genomic Profiling and ctDNA Assays. Read more about CD74-ROS1 Fusion in NSCLC Detected by Hybrid Capture-Based Tissue Genomic Profiling and ctDNA Assays.
PS01.77: Risk-Stratification for Second Primary Lung Cancer: Topic: Medical Oncology. Read more about PS01.77: Risk-Stratification for Second Primary Lung Cancer: Topic: Medical Oncology.
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016. Read more about The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.
Incidence of non-small-cell lung cancer among California Hispanics according to neighborhood socioeconomic status. Read more about Incidence of non-small-cell lung cancer among California Hispanics according to neighborhood socioeconomic status.
Cigarette smoking associated with lung adenocarcinoma in situ in a large case-control study (SFBALCS). Read more about Cigarette smoking associated with lung adenocarcinoma in situ in a large case-control study (SFBALCS).
One size does not fit all lung cancer patients. Read more about One size does not fit all lung cancer patients.
